Analysis: Pandemic fatigue makes the case for boosters a harder sell
Some nations are already looking to a fourth vaccine dose to help contend with a huge Omicron-driven spike in COVID-19 cases, but early signs suggest repeat vaccination may be a hard sell as beleaguered populations enter their third pandemic year.
Asia stocks, oil prices suffer as Omicron spreads
Asian share markets fell and oil prices slid on Monday as surging Omicron cases triggered tighter restrictions in Europe and threatened to drag on the global economy into the new year.
Wall Street firms retreat from office, holiday parties as virus spreads
Wall Street banks and investment firms are retrenching from their push to get staff back to the office, with Citigroup Inc (C.N), Goldman Sachs Group Inc (GS.N), Carlyle Group Inc (CG.O), Blackstone (BX.N) and MetLife (MET.N) among the latest to adjust plans as the Omicron variant of the coronavirus spreads.
Emirates warns Omicron could cause ‘significant traumas’ for aviation industry
A major hit to the peak December travel season because of the Omicron variant of the coronavirus would cause “significant traumas” in the global aviation business, Emirates airline President Tim Clark said on Tuesday.
Omicron vaccine warning triggers fresh global selloff
There was a fall in world share markets and scramble to safer currencies and bonds on Tuesday after the CEO of drugmaker Moderna (MRNA.O) warned that COVID-19 vaccines are unlikely to be as effective against the new Omicron variant.
Analysis: Ready to pounce: Investors prepare for swings, opportunities as Omicron variant spreads
The latest COVID-19 virus variant has sparked a wild ride in markets.
COVID-19’s epicentre again: Europe faces fresh reckoning
Europe has become the epicentre of the pandemic again, prompting some governments to consider re-imposing unpopular lockdowns in the run-up to Christmas and stirring debate over whether vaccines alone are enough to tame COVID-19.
Global COVID-19 cases hit 250 million, eastern Europe infections at record levels
Global COVID-19 cases surpassed 250 million on Monday as some countries in eastern Europe experience record outbreaks, even as the Delta variant surge eases and many countries resume trade and tourism.
Takeda eyes vaccine business growth as dengue, COVID-19 shots progress – CEO
akeda Pharmaceutical Co (4502.T), which distributes Moderna Inc’s (MRNA.O) COVID-19 shots in Japan, expects vaccines to become a bigger part of its portfolio as shots for dengue fever and COVID-19 near regulatory approval, its chief executive said.
Analysis: U.S. manufacturers take a double hit from labor and materials
Calder Brothers Corp is under pressure to raise wages after rivals lured away some of its workers. A few others were also considering jumping ship, but co-owner Glen Calder said the South Carolina-based construction machinery company managed to persuade them to stay by promising a better career.
